Anne Wojcicki co-founded 23andMe in 2006 with the big idea that informing patients about their genetics would empower them to take control of their health destinies rather than becoming slaves to the healthcare system. With more than 180,000 people who have had 23andMe analyze their genes, Wojcicki has turned the big idea into reality for many of those who have used its personal genomics service. Read the feature >>
Each of these women has been inspired and advised by others before them, and several cited the ability and willingness to surround themselves with strong mentors and to pass on their knowledge to others. Paula Brown Stafford, president of clinical development at Quintiles, spends much of her time serving as an adviser to others. And as Andrea Pfeifer of AC Immune (a 2012 Fierce 15 company) put it, as a woman in a position of power in this industry, "you become a little bit of a model for young people." Read the full report >>
Brin has put some serious dollars behind the R&D efforts, spending $132 million so far to fund programs through the Michael J. Fox Foundation and discovery work at pharma giants Pfizer and GlaxoSmithKline, Bloomberg reports.